Elutia (ELUT) Cash from Investing Activities (2019 - 2026)
Elutia (ELUT) reported Cash from Investing Activities of -$34000.0 for Q1 2026, up 87.77% on a YoY basis from -$18107.3 in Q1 2025, and down 100.04% sequentially from $79.6 million in Q4 2025.
Elutia (ELUT) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Cash from Investing Activities data on file, last reported at -$34000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 87.77% year-over-year to -$34000.0; the trailing twelve-month figure through Mar 2026 stood at $78.8 million (up 10792.4% YoY), and the FY2025 full-year result was $78.6 million, up 16673.63% from the prior year.
- Cash from Investing Activities slipped to -$34000.0 in Q1 2026, from $79.6 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $79.6 million in Q4 2025 to a low of -$630000.0 in Q3 2025.
- A 5-year average of $5.4 million and a median of -$94000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 84760.64% in 2025, while the deepest fall reached 1753.33% in 2025.
- Tracing ELUT's Cash from Investing Activities over 5 years: stood at -$134000.0 in 2022, then surged by 10948.51% to $14.5 million in 2023, then sank by 100.65% to -$94000.0 in 2024, then surged by 84760.64% to $79.6 million in 2025, then tumbled by 100.04% to -$34000.0 in 2026.
- Business Quant data shows ELUT's Cash from Investing Activities at -$34000.0 in Q1 2026, $79.6 million in Q4 2025, and -$630000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Elutia | 39.14 Mn | 10.65 Mn | 1.80 Mn | -34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Dec 31, 2025 | 79.58 Mn |
| Dec 31, 2025 | 79.58 Mn |
| Sep 30, 2025 | -630,000.00 |
| Sep 30, 2025 | -630,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Mar 31, 2025 | -278,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Sep 30, 2024 | -547,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | 14.54 Mn |
| Dec 31, 2023 | 14.54 Mn |